Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection among Kidney Transplant Recipients: A Large Single-Center Experience
Table 3
Risk factors for hospitalization.
Covariate
Univariate analyses
Multivariate analyses
HR
95% CI
HR
95% CI
Age at SARS-CoV-2 infection diagnosis (per year)
1.03
1.02–1.04
<0.001
1.03
1.02–1.04
<0.001
Male recipient
1.29
1.05–1.59
0.01
1.29
1.04–1.60
0.02
Non-white recipient
1.59
1.27–1.99
<0.001
1.48
1.17–1.88
0.001
Diabetes as a cause of ESKD vs other
2.05
1.66–2.55
<0.001
1.77
1.41–2.21
<0.001
Living donor recipient
0.69
0.56–0.85
0.006
0.91
0.72–1.13
0.40
Previous transplant
0.89
0.68–1.15
0.36
Tacrolimus + MPA + prednisone maintenance vs other
1.28
1.03–1.59
0.02
1.18
0.92–1.51
0.18
Prednisone-based immunosuppression
1.80
1.26–2.58
0.001
1.29
0.86–1.95
0.22
Treatment of rejection before SARS-CoV-2 infection
